• 1
    Scheuer PJ. Viral hepatitis. In: MacSweenRNM, AnthonyPP, ScheuerPJ, eds. Pathology of the liver. Edinburgh: Chuchill Livingstone, 1987:202 23.
  • 2
    Dienes HP, Hijtteroth T, Hess G, Meuer SC. Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology 1987; 6:1317 25.
  • 3
    Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15:572 7.
  • 4
    Luster AD. Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436 45.
  • 5
    Mackay CR. Chemokine receptors and T cell chemotaxis. J Exp Med 1996; 184:799 802.
  • 6
    Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301 14.
  • 7
    Volpes R, Van Den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12:59 65.
  • 8
    Luster AD, Unkeless JC, Ravetch JV. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315:672 6.
  • 9
    Dewald B, Moser B, Barella L, Schumacher C, Baggiolini M, Clark-Lewis I. IP-10, a γ-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties. Immunol Letters 1992; 32:81 84.
  • 10
    Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184:963 9.
  • 11
    Taub DD, Lloyd AR, Conlon K et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809 14.
  • 12
    Narumi S, Tominaga Y, Tamaru M, Shimai S, Okamura H, Nishioji K, Itoh Y, Okanoue T. Expression of interferon-inducible protein-10 (IP-10) in chronic hepatitis. J Immunol 1997; 158:5536 44.
  • 13
    Leevy CM & Tygstrup N. Standardization of nomenclature, diagnostic criteria and diagnostic methodology for diseases of the liver and biliary tract. Basel: S Karger AG, 1976.
  • 14
    Johnson PJ & McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology 1993; 18:998 1005.
  • 15
    Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315 24.
  • 16
    Tukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, Kohara M. Antigenicities of group 1 and 2 hepatitis C virus polypeptides: molecular basis of diagnosis. Virology 1993; 192:430 7.DOI: 10.1006/viro.1993.1058
  • 17
    Tanaka T, Tukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19:1347 53.
  • 18
    Tanaka T, Johnson YNL, Mizokami M et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23:742 5.
  • 19
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513 20.
  • 20
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:432 5.
  • 21
    Angerer LM, Stoler MH, Angerer RC, Valentino KL, Eberwine JH, Barchas JD, eds. New York: Oxford University Press, 1987: 42 70.
  • 22
    Narumi S, Wyner LM, Stoler MH, Tannenbaum CS, Hamilton TA. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon γ. J Leukocyte Biol 1992; 52:27 33.
  • 23
    Ohmori Y, Wyner LM, Narumi S, Armstrong D, Stoler MH, Hamilton TA. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993; 142:861 70.
  • 24
    Flier J, Boorsma DM, Bruynzeel DP, Van Beek PJ, Stoof TJ, Scheper RJ, Willemze R, Tensen CP. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 1999; 113:574 8.DOI: 10.1046/j.1523-1747.1999.00730.x
  • 25
    Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155:331 6.
  • 26
    Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K, Kashima K. Elevated interleukin-6 and γ-globulin during interferon therapy of hepatitis B. Am J Gastroenterol 1992; 87:1485 7.
  • 27
    Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989; 10:769 73.
  • 28
    Vangri P & Farber JM. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-Aα, in astrocytes and microglia. J Immunol 1994; 153:1411 8.
  • 29
    Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol 1996; 157:4511 20.
  • 30
    Wang H, Gao X, Fukumoto S, Tademoto S, Sato K, Hirai K. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol 1999; 181:361 70.DOI: 10.1002/(sici)1097-4652(199911)181:2<361::aid-jcp18>;2-9
  • 31
    Haycock C, Millward-Sadler H, Mackay C, Sheron N. Expression patterns of MIP-1α, MIP-1β, MCP-1, MCP-2, MCP-3 and IP-10 in human inflammatory liver disease. Hepatology 1996; 24:522A(Abstr.).
  • 32
    Adams DH, Hubscher S, Fear J, Jhonston J, Shaw S, Afford S. Hepatic expression of macrophage inflammatory protein-1α and macrophage inflammatory protein-1β after liver transplantation. Transplantation 1996; 61:817 25.
  • 33
    Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of Type 1 helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129 34.
  • 34
    Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark- Lewis I, Moser B. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J Immunol 1998; 28:961 72.DOI: 10.1002/(sici)1521-4141(199803)28:03<961::aid-immu961>;2-w
  • 35
    Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101:746 54.